Answers are grounded in this paper and cite their sources.
BACKGROUND: defects, as no external validation was available. Furthermore, we aimed to develop a functional test to allow the classification of variants of unknown significance (VUS) in vitro. METHODS: DNA was tested for either deletions or single nucleotide variant (SNV) and the phosphorylation of downstream pathways studied after stimulation with IGF-I by western blot analysis of fibroblast of nine patients. Functional studies showed that the SNVs tested were associated with decreased AKT phosphorylation. CONCLUSION: defects with a sensitivity of 95.2%. We developed an efficient functional test to assess the pathogenicity of SNVs, which is useful, especially for VUS.
No takes yet. Share an insight, caveat, or question.
Giabicani et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: